How has been the historical performance of Moongipa Capital?
Moongipa Capital's historical performance shows fluctuating trends, with net sales peaking at 8.06 Cr in March 2024 but declining to 7.75 Cr in March 2025, while operating profit improved to 2.16 Cr in March 2025. Total assets significantly increased to 30.54 Cr in March 2025, but cash flow from operating activities remained negative.
Answer:The historical performance of Moongipa Capital shows a fluctuating trend in its financial metrics over the years.Breakdown:
Moongipa Capital's net sales peaked at 8.06 Cr in March 2024, followed by a slight decline to 7.75 Cr in March 2025. The total operating income also saw a decrease from 9.25 Cr in March 2024 to 8.76 Cr in March 2025. Operating profit (PBDIT) excluding other income improved to 1.83 Cr in March 2025 from 1.64 Cr in March 2024, while the overall operating profit (PBDIT) increased to 2.16 Cr in March 2025. Profit before tax rose to 2.11 Cr in March 2025, up from 1.95 Cr in March 2024, and profit after tax was 1.38 Cr in March 2025, down from 1.75 Cr in March 2024. The company's total assets increased significantly to 30.54 Cr in March 2025 from 6.60 Cr in March 2024, with total liabilities also rising to 30.54 Cr. The book value per share adjusted rose to 24.94 in March 2025 from 13.26 in March 2024. Cash flow from operating activities remained negative at -1.00 Cr for both March 2024 and March 2023, while cash flow from investing activities improved to 2.00 Cr in March 2024. Overall, the financial performance of Moongipa Capital reflects a mix of growth in certain areas and challenges in maintaining profitability.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
